Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renal Management Services (RMS) is a specialized healthcare services company and a subsidiary of Fresenius Medical Care North America, focusing on comprehensive disease management for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The company provides care coordination, clinical support, and integrated pharmacy services designed to improve patient outcomes and reduce the total cost of care for renal populations. RMS partners with health plans, health systems, and physician groups to manage complex renal patients through data-driven interventions and personalized care plans. Their services include patient education, medication management, and transition support for dialysis and transplantation. By leveraging the extensive network of Fresenius Medical Care, RMS offers a holistic approach to renal health management across the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RMS Disease Management Services.